{ "labelLang" : "hun", "responseDate" : "2024-03-29 09:29", "content" : { "otype" : "JournalArticle", "mtid" : 24368670, "status" : "APPROVED", "published" : true, "unhandledTickets" : 0, "oldTimestamp" : "2018-08-09T09:42:11.000+0000", "deleted" : false, "oldId" : 14368670, "lastRefresh" : "2022-08-02T02:55:45.448+0000", "lastModified" : "2018-08-09T09:42:11.000+0000", "created" : "2015-01-04T14:35:34.000+0000", "creator" : { "otype" : "Author", "mtid" : 10007370, "link" : "/api/author/10007370", "label" : "Műzes Györgyi (belgyógyászat, klinikai immunológia)", "familyName" : "Műzes", "givenName" : "Györgyi", "published" : true, "oldId" : 10007370, "snippet" : true }, "lastDuplumOK" : "2018-10-11T14:35:48.618+0000", "lastDuplumSearch" : "2018-10-11T15:58:10.708+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Pais, P", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 37230130, "link" : "/api/authorship/37230130", "label" : "Pais, P", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Pais", "givenName" : "P", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 61173275, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 37230131, "link" : "/api/authorship/37230131", "label" : "D’Amato, M", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "D’Amato", "givenName" : "M", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 61173274, "snippet" : true } ], "title" : "In Vivo Efficacy Study of Milk Thistle Extract (ETHIS-094™) in STAM™ Model of Nonalcoholic Steatohepatitis", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 8443316, "link" : "/api/publicationidentifier/8443316", "label" : "DOI: 10.1007/s40268-014-0068-2", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "NO", "idValue" : "10.1007/s40268-014-0068-2", "realUrl" : "https://doi.org/10.1007%2Fs40268-014-0068-2", "published" : false, "oldId" : 7871867, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 8443315, "link" : "/api/publicationidentifier/8443315", "label" : "Scopus: 84919429278", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "NO", "idValue" : "84919429278", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84919429278", "published" : false, "oldId" : 7871866, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 10057026, "link" : "/api/journal/10057026", "label" : "DRUGS IN R AND D 1174-5886 1179-6901", "pIssn" : "1174-5886", "eIssn" : "1179-6901", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 10057026, "snippet" : true }, "volume" : "14", "issue" : "4", "firstPage" : "291", "lastPage" : "299", "firstPageOrInternalIdForSort" : "291", "pageLength" : 9, "publishedYear" : 2014, "digital" : null, "printed" : null, "sourceYear" : 2015, "packet" : "(Műzes Györgyi (belgyógyászat, klinikai...); 2015.01.04. 15:35:24)", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : false, "conferencePublication" : null, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2022-08-02", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 2, "citedCount" : 2, "referenceList" : "Lazo, M., Hernaez, R., Eberhardt, M.S., Prevalence of nonalcoholic fatty liver disease in the United States. The Third National Health and Nutrition Examination Survey, 1988–1994 (2013) Am J Epidemiol., 178, pp. 38-45. , PID: 23703888; \n\nChalasani, N., Younossi, Z., Lavine, J.E., The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012) Hepatology., 55, pp. 2005-2023. , PID: 22488764; \n\nAbenavoli, L., Aviello, G., Capasso, R., Milic, N., Capasso, F., Milk thistle for treatment of nonalcoholic fatty liver disease (2011) Hepat Mon., 11, pp. 173-177; \n\nPasumarthy, L., Srour, J., Nonalcoholic steatohepatitis: a review of the literature and updates in management (2010) South Med J., 103, pp. 547-550. , PID: 20710138; \n\nClark, J.M., Brancati, F.L., Diehl, A.M., The prevalence and etiology of elevated aminotransferase levels in the United States (2003) AM J Gastroenterol., 98, pp. 960-967. , COI: 1:CAS:528:DC%2BD3sXksVentro%3D, PID: 12809815; \n\nEkstedt, M., Franzén, L.E., Mathiesen, U.L., Long-term follow-up of patients with NAFLD and elevated liver enzymes (2006) Hepatology., 44, pp. 865-873. , COI: 1:CAS:528:DC%2BD28XhtFyqsrzN, PID: 17006923; \n\nBurczynski, F.J., Wang, G., Nguyen, D., Chen, Y., Smith, H.J., Gong, Y., Silymarin and hepatoprotection (2012) Zhong Nan Da Xue Xue Bao Yi Xue Ban., 37, pp. 6-10. , COI: 1:CAS:528:DC%2BC38Xksl2ms7o%3D, PID: 22349382; \n\nLi, C.C., Hsiang, C.Y., Wu, S.L., Ho, T.Y., Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis (2012) Food Chem Toxicol., 50, pp. 1568-1575. , COI: 1:CAS:528:DC%2BC38XmtVCit7s%3D, PID: 22386810; \n\nGeorge, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., Farrell, G., Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis (2003) J Hepatol., 39, pp. 756-764. , COI: 1:CAS:528:DC%2BD3sXotVertrk%3D, PID: 14568258; \n\nCohen, J.C., Horton, J.D., Hobbs, H.H., Human fatty liver disease: old questions and new insights (2011) Science., 332, pp. 1519-1523. , COI: 1:CAS:528:DC%2BC3MXnsleiurY%3D, PID: 21700865; \n\nKwon, D.Y., Ahn, C.W., Choi, Y.J., Kim, Y.C., Induction of hepatic glutathione synthesis via alterations in sulfur amino acid metabolism in mice treated with silymarin acutely (2013) FASEB J., 27 (805), p. 1; \n\nDehmlow, C., Erhard, J., de Groot, H., Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin (1996) Hepatology., 23, pp. 749-754. , COI: 1:CAS:528:DyaK28XisFygtr0%3D, PID: 8666328; \n\nLieber, C.S., Leo, M.A., Cao, Q., Ren, C., DeCarli, L.M., Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons (2003) J Clin Gastroenterol., 37, pp. 336-339. , COI: 1:CAS:528:DC%2BD3sXnsV2ks74%3D, PID: 14506392; \n\nKim, M., Yang, S.-G., Kim, J.M., Lee, J.-W., Kim, Y.S., Lee, J.I., Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells (2012) Int J Mol Med., 30, pp. 473-479. , COI: 1:CAS:528:DC%2BC38XhtlehsrzJ, PID: 22710359; \n\nReddy, K.R., Belle, S.H., Fried, M.W., Afdhal, N., Navarro, V.J., Hawke, R.L., Rationale, challenges, and participants in a phase II trial of a botanical product for chronic hepatitis C (2012) Clin Trials., 9, pp. 102-112. , PID: 22058086; \n\nSalmi, H.A., Sarna, S., Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study (1982) Scand J Gastroenterol., 17, pp. 517-521. , COI: 1:STN:280:DyaL3s%2FktV2ktg%3D%3D, PID: 6753109; \n\nFerenci, P., Dragosics, B., Dittrich, H., Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver (1989) J Hepatol., 9, pp. 105-113. , COI: 1:STN:280:DyaL1MzmtVChtg%3D%3D, PID: 2671116; \n\nFeher, J., Deak, G., Muzes, G., Hepatoprotective activity of silymarin (Legalon) therapy in patients with chronic liver disease (1989) Orv Hetil., 130, pp. 2723-2727. , COI: 1:STN:280:DyaK3c%2FpvVGntA%3D%3D, PID: 2574842; \n\nMüzes, G., Deák, G., Láng, I., Nékám, K., Niederland, V., Fehér, J., (1990) Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol). Orv Hetil, 22 (131), pp. 863-866; \n\nVelussi, M., Cernigoi, A.M., De Monte, A., Dapas, F., Caffau, C., Zilli, M., Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients (1997) J Hepatol., 26, pp. 871-879. , COI: 1:CAS:528:DyaK2sXivVGnu78%3D, PID: 9126802; \n\nSaller, R., Meier, R., Brignoli, R., The use of silymarin in the treatment of liver diseases (2001) Drugs., 61, pp. 2035-2063. , COI: 1:CAS:528:DC%2BD38XhvVGnuw%3D%3D, PID: 11735632; \n\nLucena, M.I., Andrade, R.J., de la Cruz, J.P., Rodriguez-Mendizabal, M., Blanco, E., Sánchez-de la Cuesta, F., Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study (2002) Int J Clin Pharmacol Ther, 40, pp. 2-8. , COI: 1:CAS:528:DC%2BD38Xht1ylur0%3D, PID: 11841050; \n\nLirussi, F., Okolicsanyi, L., Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease (1992) Acta Physiol Hung., 80, pp. 363-367. , COI: 1:STN:280:DyaK2c3mt1CrsQ%3D%3D, PID: 1345202; \n\nButurova, L.I., Tsybizova, T.A., Kalinin, A.V., Use of Legalon in non-alcoholic fatty liver disease [in Russian] (2010) Eksp Klin Gastroenterol, 5, pp. 69-75. , PID: 20734480; \n\nFujii, M., Shibazaki, Y., Wakamatsu, K., A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma (2013) Med Mol Morphol., 46, pp. 141-152. , COI: 1:CAS:528:DC%2BC3sXhsVOltb%2FF, PID: 23430399; \n\nKleiner, D.E., Brunt, E.M., Van Natta, M., Nonalcoholic Steatohepatitis Clinical Research Network, Design and validation of a histological scoring system for nonalcoholic fatty liver disease (2005) Hepatology., 41, pp. 1313-1321. , PID: 15915461; \n\nKlein, T., Fujii, M., Sandel, J., Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis (2013) Med Mol Morphol, , [Epub ahead of print] PubMed PMID: 24048504; \n\nTraber, P.G., Zomer, E., Therapy of experimental NASH and fibrosis with galectin inhibitors (2013) PLoS One., 8, p. e83481. , PID: 24367597; \n\nKawai, D., Takaki, A., Nakatsuka, A., Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice (2012) Hepatology., 56, pp. 912-921. , COI: 1:CAS:528:DC%2BC38Xht1Kit7jE, PID: 22505328; \n\nCynis, H., Kehlen, A., Haegele, M., Inhibition of glutaminyl cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice (2013) Int J Exp Pathol., 94, pp. 217-225. , COI: 1:CAS:528:DC%2BC3sXnvV2msrw%3D, PID: 23560443; \n\nNobili, V., Svegliati-Baroni, G., Alisi, A., Miele, L., Valenti, L., Vajro, P., A 360-degree overview of paediatric NAFLD: recent insights (2013) J Hepatol., 58, pp. 1218-1229. , PID: 23238106; \n\nHuseini, H.F., Larijani, B., Heshmat, R., The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial (2006) Phytother Res., 20, pp. 1036-1039. , COI: 1:CAS:528:DC%2BD2sXotVWntw%3D%3D, PID: 17072885; \n\nHussain, S.A., Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes (2007) J Med Food., 10, pp. 543-547. , COI: 1:CAS:528:DC%2BD2sXhtVOgt7rI, PID: 17887949; \n\nYao, J., Zhi, M., Gao, X., Hu, P., Li, C., Yang, X., Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver (2013) Braz J Med Biol Res., 46, pp. 270-277. , PID: 23532271; \n\nTrappoliere, M., Caligiuri, A., Schmid, M., Silybin, a component of silymarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells (2009) J Hepatol., 50, pp. 1102-1111. , COI: 1:CAS:528:DC%2BD1MXlslWmsrw%3D, PID: 19398228; \n\nSajedianfard, J., Behroozi, Z., Nazifi, S., The effects of a hydroalcoholic extract of silymarin on serum lipids profiles in streptozotocin induced diabetic rats (2014) Comp Clin Pathol., 23, pp. 779-784; \n\nMetwally, M.A.A., El-Gellal, A.M., El-Sawaisi, S.M., Effects of silymarin on lipid metabolism in rats (2009) World Appl Sci J., 6, pp. 1634-1637. , COI: 1:CAS:528:DC%2BD1MXhsVemtrnN", "hasCitationDuplums" : false, "userChangeableUntil" : "2015-04-04T13:38:04.000+0000", "publishDate" : "2015-01-04T14:38:04.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 1, "ownerInstituteCount" : 5, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "hasQualityFactor" : false, "link" : "/api/publication/24368670", "label" : "Pais P et al. In Vivo Efficacy Study of Milk Thistle Extract (ETHIS-094™) in STAM™ Model of Nonalcoholic Steatohepatitis. (2014) DRUGS IN R AND D 1174-5886 1179-6901 14 4 291-299", "template" : "